Executive Summary
The September 23, 2026 batch of 26 filings is dominated by routine executive and director changes, with several notable high-materiality events creating actionable signals. The most significant development is the CEO appointment at Angi Inc., where a proven turnaround leader (Michael Steib) takes over, signaling a potential strategic pivot and value creation.
However, this is counterbalanced by notable CFO/COO departures at TransUnion, Plug Power, and Galaxy Digital, which introduce execution risk for those companies, though the TransUnion guidance reaffirmation partially offsets that concern. Positive board appointments with strong operational backgrounds at Flywire, Five Below, and MeiraGTx provide expertise in critical areas (tech, retail finance, and biopharma portfolio management) that could drive shareholder value. A consistent sector theme is the 'board refresh' at several smaller companies (Terra Innovatum, Hartford Creative, AParadise), suggesting strategic realignments. The data underscores a bifurcated market where companies with stable leadership are reaffirming guidance while others in transition face heightened uncertainty.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K
Tracking the trend? Catch up on the prior US Executive Officer Management Changes SEC digest from September 22, 2026.
Investment Signals (10)
- Angi Inc. ↓ (BULLISH)▲
Appointed Michael Steib as CEO, a proven leader who tripled stock at XO Group and guided TEGNA through a premium acquisition. Signals aggressive AI-driven growth and value creation.
-
CFO Todd Cello's departure after 29 years is a loss, but the immediate reaffirmation of Q3 and full-year 2026 guidance for revenue, Adj. EBITDA, and Adj. Diluted EPS provides stability and signals strong current fundamentals. [NEUTRAL/BULLISH]
- MeiraGTx Holdings ↓ (BULLISH)▲
Appointed veteran healthcare portfolio manager Alan Sebulsky to the board. His experience managing a $2B biopharma portfolio provides critical strategic insight as the company transitions to commercial stage.
- Bath & Body Works ↓ (BULLISH)▲
CEO's $10M PSU award ties 50% of earned payout to S&P 1500 Consumer Discretionary relative TSR. This strong alignment mechanism ensures management focuses on both absolute stock price targets and relative outperformance.
- Plug Power ↓ (BEARISH)▲
COO Dean Fullerton's resignation (effective Oct 23) to take a job at another company introduces uncertainty around operational execution, especially as the company seeks to transition duties to other EVPs.
-
Planned leadership succession in Endocrinology division (Maduck retiring, Gunn taking over) is well-managed with a 3-month advisory period. Gunn's recent experience building a sales organization for a new drug launch is highly relevant for commercial expansion. [NEUTRAL/BULLISH]
- Flywire Corp ↓ (BULLISH)▲
Appointed former GitLab CTO and Google VP of Engineering to the board. Adds deep tech expertise critical for a payments company navigating the AI and software landscape.
- OneMedNet Corp ↓ (BULLISH)▲
Stockholder approval of reverse stock split (ratio up to 1:20) signals management is proactive about maintaining exchange listing requirements, reducing immediate delisting risk.
- Farmers & Merchants Bancshares ↓ (BULLISH)▲
Appointing retired CFO Mark Krebs to the board brings deep institutional financial knowledge, strengthening oversight on asset/liability and investor relations committees.
- Galaxy Digital ↓ (NEUTRAL)▲
CAO departure is a routine event, but the internal promotion of Dritan Muneka (CPA, KPMG background) ensures continuity in accounting and financial reporting.
Risk Flags (9)
- TransUnion/CFO Departure↓ [HIGH RISK]▼
Loss of a 29-year veteran CFO creates a significant leadership vacuum. The search process and integration of a new CFO pose integration risk, despite reaffirmed guidance.
- Plug Power/COO Resignation↓ [HIGH RISK]▼
COO leaving for a competitor is a red flag for operational stability. The immediate transition of duties to EVPs creates execution risk at a critical time for the hydrogen company.
- Hartford Creative Group/CEO Change↓ [MEDIUM RISK]▼
CEO resigned for health reasons, and the returning CEO (Chang) previously held the role before leaving for a month. This suggests board instability and potential strategic uncertainty.
- Terra Innovatum Global↓ [MEDIUM RISK]▼
Simultaneous resignation of three directors, even with replacement appointments, signals potential internal governance or strategic disagreements. The shift to a consulting role for one director suggests ongoing external reliance.
- AParadise Acquisition Corp. (Enhanced Group)↓ [MEDIUM RISK]▼
Two directors (Angermayer, Murren) stepped down, albeit to advisory roles. While new appointments bring expertise, the loss of key board members can indicate a shift in strategic direction or investor sentiment.
- Vertical Data Inc.↓ [LOW RISK]▼
Elimination of stockholder action by written consent and a one-third quorum requirement could make it harder for activist investors to effect change, potentially entrenching management.
- Bath & Body Works↓ [MEDIUM RISK]▼
The 50% payout reduction for the CEO's PSU award if TSR falls below the 55th percentile creates a potential 'all-or-nothing' risk for management compensation, which could incentivize riskier behavior to hit the stock price targets.
- PRA Group / Europe President Retirement↓ [MEDIUM RISK]▼
Loss of a regional president introduces leadership transition risk in the key European debt-buying market, even with a 3-month advisory period.
- Galaxy Digital / CAO Departure↓ [LOW RISK]▼
Loss of a key accounting officer at a company operating in the volatile crypto space is a concern for financial reporting continuity, partially mitigated by the internal promotion.
Opportunities (8)
- Angi Inc./New CEO Catalyst↓ (OPPORTUNITY)◆
Michael Steib's track record of tripling XO Group's stock price and selling TEGNA at a premium creates strong expectations for a strategic turnaround at Angi, likely focused on AI and margin improvement. Initiating a position before strategic details are released is a high-risk/high-reward opportunity.
- TransUnion/CFO Departure & Steady Guidance↓ (OPPORTUNITY)◆
The market may overreact to the CFO departure, creating a temporary dip. The reaffirmed guidance and strong business fundamentals (30+ countries, 13,000 associates) offer a buying opportunity for long-term investors.
- MeiraGTx Holdings/Board Expertise↓ (OPPORTUNITY)◆
The appointment of a top-tier biopharma portfolio manager (Sebulsky) signals a potential shift toward strategic portfolio management, business development, or monetization of late-stage pipeline assets (4 programs).
- Bath & Body Works/CEO Alignment↓ (OPPORTUNITY)◆
The performance-based PSU structure with stock price targets ($40, $60, $80, $100) provides a clear long-term value creation roadmap for investors. The current stock price relative to these targets indicates management’s conviction in a multi-year growth story.
- Five Below/Director Expertise↓ (OPPORTUNITY)◆
Scott Settersten, former Ulta Beauty CFO, brings proven retail scaling experience. His appointment to the audit committee can improve financial controls and strategic planning as Five Below navigates a challenging retail environment.
- Corcept Therapeutics/Succession Planning↓ (OPPORTUNITY)◆
The smooth transition of the Endocrinology division president, with the new hire building a successful sales team for a recent drug launch, is a positive catalyst for commercial execution of the Cushing’s syndrome franchise.
- Sunrise Realty Trust/Merger Catalyst↓ (OPPORTUNITY)◆
The pending merger with Southern Realty Trust (expected Q4 2026) and the addition of an independent director with 30+ years of capital markets experience (Howard Sudnow) signals a focus on deal completion and post-merger integration, potential catalyst for the stock.
- Flywire Corp/Tech Board Appointee↓ (OPPORTUNITY)◆
As a global payments company, the addition of a former CTO from a leading tech firm (GitLab) is a strong indicator that Flywire is investing in its tech platform, potentially driving innovation and competitive advantage.
Sector Themes (6)
- Board Refreshment and Strategic Pivot◆
A clear theme from 4 companies (Terra Innovatum, Hartford Creative, AParadise, Sunrise Realty) is the simultaneous departure and appointment of board members. This pattern often signals an active strategic review or a pivot in corporate strategy, with new directors bringing specialized expertise (capital markets, esports, commercialization).
-
4 of the 6 leadership departures (Boston Scientific, TransUnion, PRA Group, Corcept) include structured advisory periods of 2-4 months. This shows a best-practice approach to talent transition, reducing key-person risk and signaling board-level oversight.
- Experienced Operator Inflows◆
High-materiality board appointments (Flywire, Five Below, MeiraGTx) share a common thread: appointing seasoned operators (CTO, CFO, portfolio manager) with direct experience in the company's core business challenge (tech scaling, retail execution, pharma portfolio management), not just general governance.
- Guidance Reaffirmation as a Management Stability Signal◆
In a volatile market, TransUnion's decision to immediately reaffirm guidance along with its CFO departure announcement is a powerful signal of confidence to investors, contrasting with companies that prefer to 'clear the deck' during leadership changes.
- Emphasis on AI and Technology Leadership◆
Multiple appointments (Angi CEO, Flywire board, Edgewell role change) explicitly or implicitly tie to AI and technology strategy. This suggests a broad market trend where companies are prioritizing tech-savvy leadership to drive the next phase of growth.
- Retention Tools for Long-Term Alignment◆
Bath & Body Works (PSU with relative TSR condition), HealthStream (four-year RSU grants), and Central Plains Bancshares (employment agreement extension through 2029) show a consistent use of long-term incentive structures to align management with shareholder interests over a multi-year horizon.
Watch List (8)
-
Watch for details on which EVPs assume Fullerton's duties and whether a new COO is appointed. The transition period is short (one month), raising execution risk. Operational updates from upcoming earnings calls will be critical.
-
The quality and timing of the new CFO appointment will be the key catalyst. A strong external hire could be seen as a refresh, while an internal promotion might signal continuity. Monitor for updates on the search process.
-
Watch for the first official communications or investor day from CEO Michael Steib outlining the AI-driven growth and profitability strategy. Early read-throughs on the strategy will be a major stock catalyst.
-
The Board's decision on the specific reverse stock split ratio (between 1:5 and 1:20) will have significant implications for the stock's float and price level. The implementation date will be a key event.
-
Monitor for the closing of the merger with Southern Realty Trust, expected in Q4 2026. The addition of Howard Sudnow to the board was contingent on this event.
-
Watch the disclosed purchases by Apeiron Investment Group, the largest shareholder, which has been 'continuously increasing its stake.' This is a strong insider signal that warrants monitoring.
-
The stock price performance relative to the $40, $60, $80, and $100 hurdles, as well as the relative TSR percentile, will be a key indicator of execution. A strong start could be a positive catalyst.
-
Monitor the new division president's impact on Lifyorli sales and the Cushing's syndrome franchise, especially in the first year of leadership.
Filing Analyses
(26)
23-09-2026
Vertical Data Inc. filed an 8-K on September 23, 2026, disclosing amended and restated bylaws (Exhibit 3.1) that update governance procedures including stockholder meetings, voting, director nominations, and remote participation. The filing also covers items related to unregistered equity sales, officer changes, and amendments to articles, but the primary substantive disclosure is the adoption of the new bylaws. No financial figures or period-over-period comparisons are included in this filing.
- · The amended bylaws eliminate stockholder action by written consent (Section 12).
- · Quorum is set at one-third of outstanding shares entitled to vote (Section 6).
- · Director elections require a plurality vote; other matters require a majority of shares present (Section 10).
- · Stockholder nominations for directors are restricted to those made by the Board or by stockholders who comply with advance notice procedures (Section 14).
- · The Board, CEO, or Chair may postpone, reschedule, or cancel any previously scheduled stockholder meeting (Sections 2 & 3).
23-09-2026
Boston Scientific announced that Executive Vice President and Group President, MedSurg and Asia Pacific, Arthur C. Butcher, will retire effective January 1, 2027, and remain as a senior advisor through February 26, 2027. He will receive a prorated base salary of $780,000 during the advisory period. The company expects to enter into a retirement agreement with materially consistent benefits under existing plans.
- · Retirement effective date: January 1, 2027
- · Senior advisor period ends February 26, 2027 (Retirement Date)
- · Retirement Agreement benefits are materially consistent with Executive Retirement Plan, 2026 Annual Bonus Plan, and Long-Term Incentive Program
23-09-2026
Terra Innovatum Global N.V. (NKLR) announced the resignation of three directors (Rex Jackson, Michael Howard, and Peter Hastings) effective September 17, 2026, and the appointment of three new independent directors (Tony Tullio, Michael Modro, and Kostadin Ivanov) effective September 22, 2026. Peter Hastings will transition to a consulting role supporting commercialization efforts. The new directors will enter into standard indemnification agreements. No financial figures or performance metrics were disclosed.
- · The resignations and appointments were effective on September 17 and September 22, 2026, respectively.
- · Peter Hastings will support the Company’s ongoing commercialization efforts and related strategic initiatives in a consulting role.
- · Tony Tullio was appointed interim chairman of the Board’s Audit Committee and as a member of the Board’s Remuneration Committee.
- · Each of the Resigning Directors and Independent Directors are expected to enter into an indemnification agreement with the Company.
- · The Company is an emerging growth company as defined under the Securities Act.
23-09-2026
Angi Inc. appointed Michael Steib as CEO, succeeding Jeff Kip, effective immediately. Joey Levin transitions from Executive Chairman to Chairman. Steib, former CEO of TEGNA and XO Group, brings a focus on AI-driven growth and profitability. Kip will serve as an advisor for six months to ensure a smooth transition.
- · Michael Steib was most recently president and CEO of TEGNA, which was acquired by Nexstar Media Group at a substantial premium in March 2026.
- · At XO Group, the company's stock tripled under Steib's leadership before it merged with WeddingWire Inc.
- · Jeff Kip will serve as advisor to the company for six months.
- · Angi was founded in 1995 and has helped homeowners with more than 300 million projects.
23-09-2026
Flywire Corp announced the appointment of Sabrina Farmer, former GitLab CTO and Google VP of Engineering, to its Board of Directors, effective September 23, 2026. Ms. Farmer brings over 25 years of technology leadership and will also join the Nominating and Corporate Governance Committee. The filing contains no financial results or period-over-period comparisons, so no quantitative performance data is available.
23-09-2026
Bath & Body Works granted CEO Daniel Heaf a performance stock unit award with a target value of $10 million (591,366 shares) on September 21, 2026. The PSU Award ties vesting to four stock price hurdles ($40, $60, $80, $100) over a four-year period, with potential payouts ranging from 75% to 200% of target. However, earned PSUs are subject to a 50% reduction if the company's total shareholder return falls below the 55th percentile of the S&P 1500 Consumer Discretionary Distribution & Retail Index at the end of the period, introducing a relative underperformance risk.
- · The PSU Award is subject to a 50% reduction if the company's total shareholder return relative to the S&P 1500 Consumer Discretionary Distribution & Retail Index is below the 55th percentile at the end of the four-year performance period.
- · The award agreement is filed as Exhibit 10.1 to the 8-K.
23-09-2026
HealthStream, Inc. approved special grants of Time-Based and Performance-Based RSUs to its named executive officers on September 18, 2026, to incentivize future performance and retention. The grants include 15,395 Time-Based RSUs (grant date fair value $450,000 each) to four executives and 12,316 Time-Based RSUs ($360,000) to the CFO, along with Performance-Based RSUs of 5,132 ($150,000 each) to four executives and 4,105 ($120,000) to the CFO. The awards vest over four years, with performance-based units tied to annual targets from 2027 to 2030.
- · Time-Based RSUs vest in equal annual installments of 25% on the first, second, third, and fourth anniversaries of the grant date.
- · Performance-Based RSUs vest in equal increments of 25% based on achievement of annual performance targets for 2027, 2028, 2029, and 2030.
- · The grants were approved by the Compensation Committee of the Board of Directors.
23-09-2026
Five Below appointed Scott Settersten, former CFO of Ulta Beauty, to its Board of Directors and Audit Committee, effective September 21, 2026, expanding the board to ten directors. The appointment brings a seasoned finance leader with retail scaling experience, though no financial metrics or performance changes were disclosed in this filing.
- · Scott Settersten served as CFO of Ulta Beauty from 2012 to March 2024.
- · Settersten spent 15 years at PricewaterhouseCoopers LLP as a CPA.
- · He served as a director and audit committee member of Kimball International from July 2020 to June 2023.
- · Five Below has over 2,000 stores in 47 states.
23-09-2026
Hartford Creative Group, Inc. announced the resignation of Kewei Huang as CEO and Chairman effective September 21, 2026, due to health reasons, with no disagreement with the company. Sheng-Yih Chang has been appointed as the new CEO and Chairman, effective the same date; Chang previously served as CEO from April 1, 2024 to September 1, 2026, and will receive no additional compensation for his re-appointment.
- · Mr. Huang's resignation was effective September 21, 2026.
- · Mr. Chang previously served as CEO from April 1, 2024 through September 1, 2026 and as CFO from June 2018 through April 1, 2024.
- · Mr. Chang has been General Manager at Hartford Hotel since March 2018.
- · Mr. Chang holds a Bachelor of Science in Electrical Engineering from California State University, Northridge.
- · Mr. Chang's compensation remains unchanged from his prior CEO package; he will not receive additional compensation solely for re-appointment.
23-09-2026
Wells Fargo & Company announced the appointment of Scott E. Powell as Chief Risk Officer, effective January 15, 2027, after which he will no longer serve as Chief Operating Officer. The filing contains no financial data or period-over-period comparisons.
23-09-2026
PRA Group, Inc. announced that Owen James, President of PRA Group Europe, will retire from his role effective December 31, 2026, and will serve in an advisory capacity until March 31, 2027 to ensure a smooth transition. The filing does not include any financial results or performance metrics.
- · Owen James notified the company of his retirement on September 21, 2026.
- · His retirement as President of PRA Group Europe is effective December 31, 2026.
- · He will serve in an advisory role from January 1, 2027 through March 31, 2027.
23-09-2026
OneMedNet Corporation held its 2026 Annual Meeting on September 18, 2026, where stockholders approved all four proposals, including the election of three Class III directors, ratification of WithumSmith+Brown as independent auditor, an increase in the 2022 Equity Incentive Plan share reserve by 1,000,000 shares, and a reverse stock split authorization (ratio between 1-for-5 and 1-for-20). The reverse stock split proposal passed with strong support (41,068,200 votes for, 739,329 against), while the equity plan amendment received the lowest approval percentage (about 94.6% of votes cast, excluding broker non-votes). The company remains an emerging growth company and has not elected to use the extended transition period for new accounting standards.
- · The reverse stock split authorization allows the Board to determine a ratio between 1-for-5 and 1-for-20, with no specific ratio selected yet.
- · The 2022 Plan amendment became effective immediately upon stockholder approval at the Annual Meeting.
- · The company is an emerging growth company and has not elected to use the extended transition period for complying with new or revised financial accounting standards.
- · The Annual Meeting was held virtually via live audio webcast.
- · The proxy statement for the Annual Meeting was filed on August 19, 2026.
23-09-2026
TransUnion (NYSE: TRU) announced that CFO Todd Cello will step down on December 31, 2026, after 29 years with the company, including nine years as CFO. He will serve as a full-time advisor through March 1, 2027, to ensure a smooth transition. The company has initiated a CFO search with a leading executive search firm and reaffirmed its Q3 and full-year 2026 guidance for revenue, Adjusted EBITDA, and Adjusted Diluted EPS, stating the departure will not impact operations, strategic priorities, or capital allocation.
- · TransUnion operates in more than 30 countries with over 13,000 associates.
- · The company reaffirmed its Q3 and full-year 2026 guidance for revenue, Adjusted EBITDA, and Adjusted Diluted EPS.
- · Cello will remain CFO through December 31, 2026, and serve as a full-time advisor until March 1, 2027.
- · The CFO search is being conducted in partnership with a leading executive search firm.
23-09-2026
LiveOne, Inc. held its 2026 Annual Meeting on September 17, 2026, where all seven director nominees were elected and the new 2026 Equity Incentive Plan was approved by stockholders. The plan reserves 4,000,000 shares of common stock and replaces the expired 2016 Equity Incentive Plan. The ratification of Macias Gini & O'Connell, LLP as independent auditor for fiscal year ending March 31, 2027, was also approved with overwhelming support (8,430,988 for, 132,537 against).
- · The 2026 Equity Incentive Plan was approved with 4,511,114 votes for, 624,075 against, and 20,777 abstained.
- · All seven director nominees were elected with over 5.1 million votes for each and fewer than 55,000 withheld votes.
- · The ratification of the independent auditor received 8,430,988 votes for, 132,537 against, and 1,423 abstained.
- · The proposal to adjourn the Annual Meeting if necessary was approved with 7,985,029 votes for, 573,424 against, and 6,492 abstained.
- · No awards or shares have been issued under the 2026 Plan as of the filing date.
23-09-2026
Sunrise Realty Trust, Inc. (SUNS) filed an 8-K on September 23, 2026, disclosing that its Board increased its size to six directors and approved the appointment of Howard Sudnow as an independent director, effective at the closing of the pending merger with Southern Realty Trust Inc. (SRT), expected in Q4 2026. Mr. Sudnow, a Partner at MYST Advisors with over 30 years of capital markets experience, will serve until the 2027 annual meeting. No financial metrics or performance data were included in this filing.
- · Merger with SRT expected to close in Q4 2026
- · Mr. Sudnow has not been appointed to any Board committee as of the filing date
- · Mr. Sudnow has no family relationships with SUNS directors or executive officers
- · Mr. Sudnow will receive standard non-employee director compensation
- · Mr. Sudnow's prior roles include Managing Director of Institutional Sales at Seaport Global and similar role at Sterne Agee (2013-2016)
23-09-2026
Plug Power Inc. announced that COO Dean C. Fullerton will resign effective October 23, 2026, to accept a position at another company. The resignation is not due to any disagreement with the company, and Fullerton will assist with transitioning his duties to other executives. The company expressed gratitude for his contributions.
- · Resignation effective October 23, 2026
- · Duties to be transitioned to certain Executive Vice Presidents and Vice Presidents
- · Filing date: September 23, 2026
23-09-2026
Enhanced Group Inc. (NYSE: ENHA) announced board changes, appointing Mike Sepso (co-founder of Major League Gaming) to the Board and Audit Committee, naming James Simpson Chairman, and Tony Eisenberg Audit Committee Chair. Christian Angermayer and Jim Murren stepped down from the Board but remain in advisory roles; Apeiron Investment Group, the largest shareholder, has been increasing its stake. The changes reflect continuity and fresh expertise, though the departure of two directors signals a shift in governance.
- · Apeiron Investment Group, Enhanced's largest shareholder, has been increasing its stake continuously over the past weeks.
- · Mike Sepso co-founded Vindex, a gaming and esports technology infrastructure company acquired by ESL FACEIT Group in 2023.
- · Jim Murren will serve as Special Advisor to the CEO after stepping down from the Board.
- · Christian Angermayer remains Co-Founder and continues through Apeiron Investment Group.
23-09-2026
Tri-State Generation & Transmission Association, Inc. announced the election of Amy Miller as a director representing Wheatland Rural Electric Association on its Board of Directors, effective September 22, 2026. Mrs. Miller is expected to serve on the External Affairs-Member Relations Committee. This is a routine board appointment with no financial impact disclosed.
23-09-2026
IIOT-OXYS, Inc. appointed Vidhyadhar Mitta as a director on September 21, 2026, effective immediately. Mr. Mitta previously served as a director and had entered into a Debt Exchange Agreement in October 2025, exchanging $216,156 of principal and accrued interest for 180 shares of Series E Preferred Stock and canceling 12,000 shares of Series A Preferred Stock. The filing does not include any financial results or period-over-period comparisons.
- · Mr. Mitta previously served as a director of the Company.
- · The Board does not have any committees, and Mr. Mitta has not been named to any committee.
- · The Debt Exchange Agreement was entered into on October 30, 2025, and closed on November 5, 2025.
- · The 12% Secured Convertible Promissory Note was issued to Mr. Mitta on August 2, 2019.
- · No other transactions between the Company and Mr. Mitta require disclosure under Item 404(a) of Regulation S-K.
23-09-2026
Valion Bio, Inc. (Nasdaq: VBIO) announced the appointment of board member Dean Zikria as Interim CEO, succeeding Sheryle Bolton who stepped down from the Board. Thomas Jensen was appointed Chair of the Board and Compensation Committee, and Jared Malbin was appointed Chair of the Audit Committee. The leadership changes aim to sharpen execution as the company advances its lead candidate Entolimod and evaluates strategic, commercial, and government opportunities. No financial metrics or performance data were disclosed in the filing.
- · Dean Zikria previously co-invented therapeutics for traumatic brain injury, hemorrhagic shock, and battlefield medicine at Columbia University Medical Center.
- · He spent seven years at Pfizer in strategy and business development roles within its $7 billion U.S. cardiovascular business.
- · Lisa Wolf continues as President, COO, and CFO, reporting to Mr. Zikria.
- · Entolimod has received Fast Track and Orphan Drug designations from the FDA and is being developed under the FDA's Animal Rule.
- · Valion's subsidiary Velocity Bioworks is a biologics CDMO supporting internal pipeline development.
23-09-2026
Edgewell Personal Care announced that LaTanya Langley will become Chief Administrative and Legal Officer and Corporate Secretary effective October 1, 2026, and will no longer serve as Chief People Officer. No changes to her compensation were disclosed. This is a routine executive role change with no financial impact.
- · Effective date of role change: October 1, 2026
- · Ms. Langley will retain the title of Chief Legal Officer (as indicated by her signature block)
- · No compensation changes in connection with the role change
23-09-2026
Corcept Therapeutics announced that Sean Maduck, President of the Endocrinology division, will retire, with Justin Gunn succeeding him effective October 1, 2026. Maduck will remain as a senior commercial advisor to ensure a smooth transition. The leadership change is part of the company's ongoing focus on expanding its Endocrinology business, particularly for Cushing's syndrome.
- · Justin Gunn joined Corcept in July 2024 as VP of Sales and Commercial Learning for the Oncology division.
- · Gunn built the field sales and training organization for Lifyorli, approved for platinum-resistant ovarian cancer.
- · Maduck will serve as senior commercial advisor during the transition.
- · Corcept has discovered over 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists.
- · Advanced clinical trials are ongoing in hypercortisolism, solid tumors, ALS, and liver disease.
23-09-2026
MeiraGTx Holdings plc appointed veteran healthcare portfolio manager Alan M. Sebulsky to its Board of Directors, effective September 23, 2026. Mr. Sebulsky brings over 40 years of experience, most recently as Partner and Portfolio Manager at Adage Capital Management, where he oversaw a $2 billion biopharmaceutical portfolio. The appointment is part of MeiraGTx's transformation into a commercial-stage company, with no negative or flat metrics disclosed in this filing.
- · Mr. Sebulsky reestablished Apothecary Capital in April 2026 and currently serves as Managing Member.
- · He holds an M.S. in finance and a B.B.A. in finance and economics from the University of Wisconsin–Madison.
- · MeiraGTx has four late-stage clinical programs targeting the eye, radiation-induced xerostomia, and Parkinson's disease.
- · The company has two GMP-licensed viral vector production facilities and a GMP QC facility with clinical and commercial licensure.
23-09-2026
Galaxy Digital Inc. announced that Robert Rico will resign as Chief Accounting Officer and principal accounting officer effective September 30, 2026, to pursue an opportunity outside the company. Dritan Muneka, currently Head of Accounting Policy, has been appointed as the new PAO with the title Corporate Controller, effective the same date. No compensation arrangements or family relationships were disclosed in connection with the appointment.
- · Dritan Muneka, age 40, has served as Head of Accounting Policy since May 2022.
- · Prior to Galaxy, Muneka was at KPMG LLP from November 2010 to April 2022, ending as Managing Director.
- · Muneka holds a bachelor's degree in economics and a master's degree in international relations from Monash University and is a CPA.
- · No family relationships or material interests in transactions requiring disclosure under Item 404(a) were reported.
- · Muneka will enter into the company's standard Indemnification Agreement (Exhibit 10.2 to Form S-4 filed January 28, 2022).
Get daily alerts with 10 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 26 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Executive Officer Management Changes SEC
September 21, 2026
US Executive Officer Management Changes SEC — September 21, 2026
September 18, 2026
US Executive Officer Management Changes SEC — September 18, 2026
September 17, 2026
US Executive Officer Management Changes SEC — September 17, 2026
September 16, 2026
US Executive Officer Management Changes SEC — September 16, 2026
🇺🇸 More from United States
View all →September 23, 2026
US Pre-Market SEC Filings Roundup — September 23, 2026
US Pre-Market SEC Filings Roundup
September 23, 2026
USA Corporate Events Calendar — September 23, 2026
USA Corporate Events Calendar
September 23, 2026
USA Insider Trading Pulse — September 23, 2026
USA Insider Trading Pulse
September 23, 2026
US SEC Trading Suspension Halt Orders — September 23, 2026
US SEC Trading Suspension Halt Orders